Issues affecting the 340B drug pricing program; appropriations for 340B program
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 14, 2026
- Income
- $39,000.00
- Expenses
- Not reported
- Registrant
- WAXMAN STRATEGIES
- Client
- 340B HEALTH
- Filing UUID
- 04100327-536a-4d7f-90e1-bb500c2526fd
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.